Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0072-2027

VERIFY Dual Species Self-Contained Biological Indicator Recall

VERIFY Dual Species Self-Contained Biological Indicator Model/Catalog Number: S3060

FDA recall Class II

Ongoing

FDA lists this Class II recall for VERIFY Dual Species Self-Contained Biological Indicator. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0072-2027
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 31, 2026
FDA report date
Oct 14, 2026
Quantity in commerce
1185
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

VERIFY Dual Species Self-Contained Biological Indicator Model/Catalog Number: S3060

Affected model & UDI checker

Search the exact identifiers published for Z-0072-2027.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
S3060VERIFY Dual Species Self-Contained Biological IndicatorCheck source noticeNot specified
Not specifiedVERIFY Dual Species Self-Contained Biological IndicatorCheck source notice10724995023833
FDA code information

UDI: 10724995023833 Lot numbers: 260810: expiration date - 08/10/2026 260810A: expiration date - 08/10/2026 261106: expiration date - 11/06/2026 270116: expiration date - 01/16/2027 270302: expiration date - 03/02/2027

View the original FDA recall notice

Why was this product recalled?

Geobacillus stearothermophilus spore population in affected products may fall below minimum shelf life specification. When used to monitor steam sterilization cycles, the potential hazard is that the biological indicator will show no growth, indicating that the steam cycle was effective, even if the steam cycle did not achieve the intended spore reduction

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did STERIS CORPORATION take?

Firm began notifying customers on August 31, 2026 via URGENT MEDICAL DEVICE RECALL letters. Customers were instructed to destroy any affected product on hand. The firm will replace any product still within its shelf life.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology